Etanercept reduces the serum levels of macrophage chemotactic protein-1 in patients with rheumatoid arthritis
スポンサーリンク
概要
- 論文の詳細を見る
- 2009-08-01
著者
-
Kato Norihiko
Department Of Orthopaedic Surgery Heisei Memorial Hospital
-
Kato Norihiko
Department Of Mechanical Eng Mie University
-
Kobayashi Hayato
Department Of Orthopaedic Surgery Heisei Memorial Hospital
-
Kageyama Yasunori
Department Of Orthopaedic Surgery Hamamatsu University School Of Medicine
-
Kageyama Yasunori
Department Of Orthopaedic Surgery Heisei Memorial Hospital
-
SHIMAZU Masahiro
Department of Orthopaedic Surgery, Shimazu Clinic
-
Shimazu Masahiro
Department Of Orthopaedic Surgery Shimazu Clinic
関連論文
- Comparison between resection arthroplasty alone and resection arthroplasty with arthrodesis of the first MTP joint for rheumatoid forefoot deformities
- Methotrexate reduces the levels of pentosidine and 8-hydroxy-deoxy guanosine in patients with rheumatoid arthritis
- The effect of methotrexate on bone metabolism markers in patients with rheumatoid arthritis
- Osteoma Arising From the Lumbar Articular Process : Case Report
- Reduction of bone mineral density in rheumatoid arthritis: A longitudinal study
- IM-08 A BASIC STUDY ON A FACE-TO-FACE IMAGE PRESENTATION SYSTEM
- Path Planning Algorithm-How to Evaluate the Difficulties of Moving in Various Environment
- Infliximab treatment reduces the serum levels of interleukin-23 in patients with rheumatoid arthritis
- Etanercept reduces the serum levels of macrophage chemotactic protein-1 in patients with rheumatoid arthritis